Forex News
Liberty Star Contracts for Core Drilling at Gold Prospect Red Rock Canyon and Copper Hay Mountain Project in SE Arizona
Liberty Star Contracts for Core Drilling at Gold Prospect Red Rock Canyon and Copper Hay Mountain Project, SE Arizona TUCSON, AZ, Nov. 21, 2023 (GLOBE NEWSWIRE) — Liberty Star Minerals (“Liberty Star” or the “Company”) (OTCMarkets: LBSR) announces that it has engaged NISS Drilling Services to undertake diamond core drilling at Liberty Star’s Red Rock…
CAD/JPY Short Forecast: An Update and Follow-Up by Vladimir Ribakov
Hi Traders! CADJPY short term forecast update and follow up Recapping the Previous Forecast On November 1st, I shared a post on CADJPY Technical Analysis and Short Term Forecast. In that post, we analyzed the setup and provided our forecast. Today, let’s do a recap of that analysis and see how the market has evolved…
Revolutionizing Treatment: Nexcella’s CAR-T NXC-201 Receives FDA Approval for U.S. Patient Dosing
Nexcella Announces Expansion of NXC-201 Studies in Relapsed/Refractory AL Amyloidosis About NEXICART-2 Clinical Trial Nexcella, Inc. has announced the expansion of the NEXICART-2 clinical trial to U.S. sites following clearance of the Investigational New Drug (IND) application. This decision comes after positive results from the initial study involving 72 patients who were previously dosed with…
Turkey Time: How MariMed Spreads Holiday Cheer with Annual Donations to Worthy Causes and Customers!
Thanksgiving Without the Tur-key Worries! Let’s Talk Turkey Gobble Gobble! Are you ready for the most delicious and stressful holiday of the year? That’s right, Thanksgiving is just around the corner and while we may be excited to gather with loved ones and stuff our faces with all the fixings, there’s one thing that can…
Breaking Boundaries: Preclinical Data of Panavances’ Misetionamide GP-2250 in Melanoma Published by International Journal of Molecular Sciences
Misetionamide: A New Hope for BRAF-Mutated Melanoma Treatment Introduction: Misetionamide is proving to be a game-changer in the field of oncology, specifically in the treatment of BRAF-mutated melanoma. This type of melanoma accounts for about half of all melanoma cases and has been notoriously challenging to treat effectively. However, Panavance Therapeutics Inc. has been making…
¡Hola España! Biocryst Unleashes Orladeyo (aka Berotralstat) onto the Market
Welcome to the Weird and Wonderful World of ORLADEYO® (berotralstat)! What’s the Buzz About BioCryst’s Latest Launch? Nestled in the heart of Research Triangle Park, North Carolina, BioCryst Pharmaceuticals, Inc. is making waves in the pharmaceutical world with their newest product: ORLADEYO® (berotralstat). This groundbreaking medication has just received marketing authorization from the Spanish Ministry…
Augmedix Successfully Closes Public Offering of Common Stock, Securing Additional Investments from HCA Healthcare and Redmile Group
Augmedix Announces Closing of Public Offering of Common Stock, Including Incremental Capital for Expansion SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) — Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, has just announced the successful closing of a registered public offering of common stock. This move…
Rev Up Your Ride: Beam Global Scores European Patent for Curbside Electric Vehicle Chargers!
Welcome to the Future of Curbside Charging! What’s the Buzz About Beam Global’s Latest Patent? Hey there, tech-savvy readers! Have you heard the news? Beam Global, the innovative folks behind electrification of transportation and energy security, have just been granted a shiny new patent by the European Patent Office. This time, it’s all about their…